Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AAO Highlights: Back (of the Eye) to the Future

Executive Summary

The 2009 meeting of the American Academy of Ophthalmology showcased the latest developments in cataract/refractive surgery, glaucoma, retina, and other ophthalmic subspecialties. The cataract/refractive surgery market has been under significant economic pressure recently due to a recessionary drop in elective ophthalmic procedures. However, evolving treatments for "back of the eye" conditions, such as age-related macular degeneration (AMD) and diabetic retinopathy, are making significant inroads toward improved patient outcomes for these common and devastating diseases and continue to energize the retina products market.
Advertisement

Related Content

Devices Expand Their Role in Retinal Disease
Devices Expand Their Role in Retinal Disease
Laser Cataract Surgery Comes into Focus at ASCRS
Market & Industry Briefs
CMS Reverses Avastin Reimbursement Limits For Macular Degeneration In Physicians' Office
ESCRS 2009: The Next Wave in Cataract and Presbyopia Devices
ESCRS 2009: The Next Wave in Cataract and Presbyopia Devices
Venture Eyes Ophthalmology--And Likes What It Sees

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT035304

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel